Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 34% ± 17% | |
fibroblast | 6 studies | 35% ± 10% | |
GABAergic neuron | 4 studies | 38% ± 10% | |
interneuron | 3 studies | 27% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 86% | 667.13 | 211 / 245 | 69% | 3.06 | 346 / 502 |
brain | 69% | 566.99 | 1824 / 2642 | 64% | 4.42 | 450 / 705 |
lung | 98% | 618.06 | 567 / 578 | 20% | 0.87 | 232 / 1155 |
intestine | 94% | 995.40 | 904 / 966 | 14% | 0.67 | 74 / 527 |
stomach | 85% | 896.42 | 306 / 359 | 20% | 0.95 | 58 / 286 |
esophagus | 74% | 702.37 | 1064 / 1445 | 14% | 0.33 | 25 / 183 |
bladder | 52% | 199.24 | 11 / 21 | 11% | 0.38 | 56 / 504 |
blood vessel | 32% | 76.02 | 433 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 22% | 2.23 | 50 / 230 |
uterus | 5% | 34.52 | 9 / 170 | 10% | 1.24 | 45 / 459 |
liver | 1% | 1.48 | 3 / 226 | 11% | 0.55 | 46 / 406 |
ovary | 10% | 16.24 | 18 / 180 | 1% | 0.07 | 3 / 430 |
pancreas | 0% | 0 | 0 / 328 | 10% | 0.62 | 18 / 178 |
adipose | 5% | 7.77 | 58 / 1204 | 0% | 0 | 0 / 0 |
heart | 4% | 5.21 | 31 / 861 | 0% | 0 | 0 / 0 |
skin | 0% | 0.19 | 3 / 1809 | 2% | 0.18 | 11 / 472 |
breast | 0% | 0.47 | 1 / 459 | 1% | 0.03 | 15 / 1118 |
thymus | 0% | 0.13 | 1 / 653 | 1% | 0.05 | 7 / 605 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 8 / 901 |
muscle | 0% | 0.56 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060437 | Biological process | lung growth |
GO_0060173 | Biological process | limb development |
GO_0035115 | Biological process | embryonic forelimb morphogenesis |
GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
GO_0060441 | Biological process | epithelial tube branching involved in lung morphogenesis |
GO_0060535 | Biological process | trachea cartilage morphogenesis |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0030282 | Biological process | bone mineralization |
GO_0042489 | Biological process | negative regulation of odontogenesis of dentin-containing tooth |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0008201 | Molecular function | heparin binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RSPO2 |
Protein name | R-spondin 2 R-spondin-2 (Roof plate-specific spondin-2) (hRspo2) |
Synonyms | UNQ9384/PRO34209 |
Description | FUNCTION: Activator of the canonical Wnt signaling pathway by acting as a ligand for LGR4-6 receptors. Upon binding to LGR4-6 (LGR4, LGR5 or LGR6), LGR4-6 associate with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. Also regulates the canonical Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling by acting as an inhibitor of ZNRF3, an important regulator of the Wnt signaling pathway . During embryonic development, plays a crucial role in limb specification, amplifying the Wnt signaling pathway independently of LGR4-6 receptors, possibly by acting as a direct antagonistic ligand to RNF43 and ZNRF3, hence governing the number of limbs an embryo should form . . |
Accessions | Q6UXX9 ENST00000517939.5 [Q6UXX9-2] E5RH25 E5RGU9 ENST00000521956.5 ENST00000276659.10 [Q6UXX9-1] ENST00000522333.1 ENST00000666252.1 A0A590UJ52 ENST00000517781.5 [Q6UXX9-3] |